Connect with us

National

Immigration rally includes LGBT voices

Bi-national couples seek inclusion in reform

Published

on

(DC Agenda video by Steve Fox)

An estimated 200,000 demonstrators descended on the National Mall on Sunday to urge passage of comprehensive immigration reform, including several hundred protesters advocating for LGBT inclusion in the legislation.

As they danced to salsa music and listened to speeches, participants at the rally and the march that followed called on President Obama and Congress to keep their promise to enact reform legislation before the year’s end.

Latino groups — waiving signs reading “Reform not Raids” and “Obama Cumple tu Promesa” — comprised the majority of those participating in the demonstration, although contingents of Asian and Caribbean groups also took part.

The LGBT contingent, which included about 300 people, advocated for their inclusion as part of the broader immigration movement as well as for incorporating the Uniting American Families Act in reform. The bill would enable LGBT Americans to sponsor same-sex partners who are foreign nationals for residency.

Rachel Tiven, executive director of Immigration Equality, said the showing was “a nice visible contingent” that demonstrated “how much the LGBT community is here for comprehensive immigration reform that includes all families.”

“First and foremost, we hope to really be a part of the movement that’s pushing for [comprehensive immigration reform] to get going,” she said. “Nobody knows better than [LGBT] families how badly we need immigration reform in this country.”

Advocates are pushing Sens. Chuck Schumer (D-N.Y.) and Lindsey Graham (R-S.C.), who are developing bi-partisan comprehensive immigration reform legislation, to include UAFA in the version of the bill they introduce in the U.S. Senate.

As they marched among other groups, members of Immigration Equality’s contingent sported red shirts with “LGBT families for immigration reform” on the back as they chanted, “Two, four, six, eight! Let our families immigrate!” and “We’re here! We’re queer! You are not alone!”

A number of demonstrators had a personal stake in the passage of legislation to protect bi-national same-sex couples. Eric Stanley, a D.C. resident, and Tim Lin, his partner of nearly four years from Taiwan, said they want UAFA passed so they can remain together in the United States.

Under current law, they said it would take Lin seven to 10 years for him to receive a green card to remain in the country.

“If I could marry him and give a green card, I would,” Stanley said. “It feels like Kansas controls what the rest of country has to do in this situation.”

Although they’re pushing hard for LGBT-inclusive immigration reform, Lin said he isn’t optimistic that reform will pass this year.

“I’m just hoping that with all these people, they might start to think about it this year, and eventually, in a year or two, do something about it,” he said.

Stanley also said he doesn’t think many LGBT people view protection for bi-national couples as a priority.

“People who are not directly affected don’t seem very interested,” he said. “I couldn’t get any friends to come today. But when you are directly affected, it does matter quite a bit.”

Guillermo Lopez, 22, a gay U.S. citizen and student at Houston Community College, said he came to the march in D.C. to support same-sex bi-national couples, even though he’s not in a relationship that would benefit from passage of the Uniting American Families Act.

“If these people were straight or were in heterosexual relationships, they could easily sponsor their partners and give them legal status,” he said. “So we’re here trying to push for the Uniting American Families Act, which would bring that equality so that gay people can sponsor their partner.”

Lopez said he thinks the rally put pressure on President Obama and Congress to pass comprehensive immigration reform.

“Hopefully it’ll put enough pressure on them so that a comprehensive reform bill will pass in 2010 before Democrats lose seats in the election, which will make it harder for us to push our agenda,” he said.

Before marching past the U.S. Capitol to Robert F. Kennedy Memorial Stadium, demonstrators gathered on the Mall where a series of speakers rallied the crowd. The issue of helping same-sex couples was only mentioned a few times.

A female speaker at the event said immigration reform is supported by many groups, including “disabled and queer people.” Rep. Mike Honda (D-Calif.), whose Reuniting American Families Act includes language similar to UAFA, was introduced at the event as someone who wants gay and lesbian families included in reform.

Rep. Jared Polis (D-Colo.), a gay lawmaker, joined a group of members of Congress on stage who support immigration reform.

Speakers at the event worked to invigorate the crowd. Rep. Luis Gutierrez (D-Ill.), a champion of immigrant rights, was received particularly favorably by attendees, as he urged them to continue to pressuring lawmakers to enact reform.

“If today we will raise our voices in hope, then soon we will raise our voices in victory,” he said. “Because our day is coming. Together, we will turn today’s hope into tomorrow’s victory.”

Gutierrez late last year introduced in the U.S. House a version of immigration reform intended as a more liberal alternative to the working bill expected later in the House. But Gutierrez’s bill lacks a provision similar to the Uniting American Families Act.

Ali Noorani, executive director of the National Immigration Forum, a group leading the charge for reform, also had encouraging words for his audience.

“We will keep the pressure on until comprehensive immigration reform is finally passed,” he said. “So from here, our power will only grow.”

In addition to Immigration Equality, other LGBT organizations participated in the demonstration, including the Human Rights Campaign, the Latino GLBT History Project and the National Gay & Lesbian Task Force.

Rea Carey, the Task Force’s executive director, said her organization participated to emphasize immigration as an LGBT issue.

In addition to ensuring that bi-national same-sex couples can stay together in the United States, Carey said there also are issues related to transgender people and HIV-positive detainees not receiving needed treatment while in custody that need to be addressed.

“We are here today because we want to make sure the broad range of issues that affect LGBT people are recognized in the context of immigration reform,” she said.

Lt. Dan Choi, a gay U.S. Army Iraq war veteran who was arrested last week for chaining himself to the White House gates in protest of “Don’t Ask, Don’t Tell,” joined the LGBT contingent in the rally. He said he wouldn’t take questions because the day was focused on the immigration rally.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular